HRPK20030766B3 - Combination of a taxane and cyclin-dependent kinase inhibitor - Google Patents

Combination of a taxane and cyclin-dependent kinase inhibitor

Info

Publication number
HRPK20030766B3
HRPK20030766B3 HR20030766A HRP20030766A HRPK20030766B3 HR PK20030766 B3 HRPK20030766 B3 HR PK20030766B3 HR 20030766 A HR20030766 A HR 20030766A HR P20030766 A HRP20030766 A HR P20030766A HR PK20030766 B3 HRPK20030766 B3 HR PK20030766B3
Authority
HR
Croatia
Prior art keywords
cyclin
taxane
combination
dependent kinase
kinase inhibitor
Prior art date
Application number
HR20030766A
Other languages
English (en)
Croatian (hr)
Inventor
Bissery Marie-Christine
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HRP20030766A2 publication Critical patent/HRP20030766A2/hr
Publication of HRPK20030766B3 publication Critical patent/HRPK20030766B3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20030766A 2001-03-23 2003-09-22 Combination of a taxane and cyclin-dependent kinase inhibitor HRPK20030766B3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27794801P 2001-03-23 2001-03-23
US30269201P 2001-07-05 2001-07-05
US33491601P 2001-12-04 2001-12-04
PCT/EP2002/004083 WO2002076484A2 (en) 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase inhibitor

Publications (2)

Publication Number Publication Date
HRP20030766A2 HRP20030766A2 (en) 2005-06-30
HRPK20030766B3 true HRPK20030766B3 (en) 2006-11-30

Family

ID=27402954

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030766A HRPK20030766B3 (en) 2001-03-23 2003-09-22 Combination of a taxane and cyclin-dependent kinase inhibitor

Country Status (33)

Country Link
US (2) US20020182204A1 (xx)
EP (1) EP1372652B1 (xx)
JP (1) JP2004521140A (xx)
KR (1) KR100879712B1 (xx)
CN (1) CN1498107A (xx)
AR (1) AR034222A1 (xx)
AT (1) ATE395917T1 (xx)
AU (1) AU2002312815B2 (xx)
BR (1) BR0208221A (xx)
CA (1) CA2441441C (xx)
CY (1) CY1110449T1 (xx)
CZ (1) CZ301423B6 (xx)
DE (1) DE60226710D1 (xx)
DK (1) DK1372652T3 (xx)
EA (1) EA007815B1 (xx)
ES (1) ES2305253T3 (xx)
HR (1) HRPK20030766B3 (xx)
HU (1) HU229258B1 (xx)
IL (2) IL158058A0 (xx)
ME (1) MEP16408A (xx)
MX (1) MXPA03007743A (xx)
NO (1) NO332441B1 (xx)
NZ (1) NZ527655A (xx)
PE (1) PE20020907A1 (xx)
PL (1) PL206118B1 (xx)
PT (1) PT1372652E (xx)
RS (1) RS50681B (xx)
SI (1) SI1372652T1 (xx)
SK (1) SK287481B6 (xx)
TW (1) TWI355935B (xx)
UY (1) UY27220A1 (xx)
WO (1) WO2002076484A2 (xx)
ZA (1) ZA200307381B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487434B1 (en) * 2002-03-06 2007-05-09 The Medical Research and Education Trust Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin
AU2003287081A1 (en) * 2002-10-16 2004-05-04 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
ES2318202T3 (es) * 2002-11-06 2009-05-01 Cyclacel Limited Combinacion que comprende docetaxel y un inhibidor de cdk.
CA2623729A1 (en) * 2006-02-10 2007-08-16 Nerviano Medical Sciences S.R.L. Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
US20130237582A1 (en) * 2010-11-19 2013-09-12 Piramal Enterprises Limited Pharmaceutical combination of paclitaxel and a cdk inhibitor
BR112013025410A2 (pt) * 2011-04-01 2016-12-20 Astrazeneca Ab tratamento terapêutico
PT2785349T (pt) 2011-11-30 2019-12-11 Astrazeneca Ab Tratamento combinado de cancro
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
EP0888458A4 (en) * 1996-02-20 2004-05-06 Sloan Kettering Institutefor C COMBINATION OF PROTEIN KINASE C INHIBITORS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

Also Published As

Publication number Publication date
CA2441441C (en) 2009-05-26
EA200301053A1 (ru) 2004-02-26
YU69503A (sh) 2006-08-17
EA007815B1 (ru) 2007-02-27
US20020182204A1 (en) 2002-12-05
HU229258B1 (en) 2013-10-28
PL206118B1 (pl) 2010-07-30
AU2002312815B2 (en) 2006-08-24
ATE395917T1 (de) 2008-06-15
PE20020907A1 (es) 2002-12-19
NZ527655A (en) 2006-03-31
RS50681B (sr) 2010-06-30
PT1372652E (pt) 2008-07-24
HUP0303589A2 (hu) 2004-03-01
TWI355935B (en) 2012-01-11
CY1110449T1 (el) 2015-04-29
SK11692003A3 (sk) 2004-03-02
EP1372652A2 (en) 2004-01-02
JP2004521140A (ja) 2004-07-15
WO2002076484A2 (en) 2002-10-03
ZA200307381B (en) 2005-03-30
DK1372652T3 (da) 2008-09-22
KR20030086318A (ko) 2003-11-07
PL367702A1 (en) 2005-03-07
NO20034124D0 (no) 2003-09-16
CA2441441A1 (en) 2002-10-03
AR034222A1 (es) 2004-02-04
CZ301423B6 (cs) 2010-02-24
CN1498107A (zh) 2004-05-19
UY27220A1 (es) 2002-09-30
MXPA03007743A (es) 2004-11-12
KR100879712B1 (ko) 2009-01-22
NO332441B1 (no) 2012-09-17
MEP16408A (en) 2010-10-10
WO2002076484A3 (en) 2003-01-03
BR0208221A (pt) 2004-03-02
HRP20030766A2 (en) 2005-06-30
NO20034124L (no) 2003-09-16
IL158058A0 (en) 2004-03-28
SK287481B6 (sk) 2010-11-08
ES2305253T3 (es) 2008-11-01
HUP0303589A3 (en) 2007-05-02
CZ20032551A3 (en) 2004-07-14
DE60226710D1 (de) 2008-07-03
SI1372652T1 (sl) 2008-10-31
EP1372652B1 (en) 2008-05-21
IL158058A (en) 2010-02-17
US20060128640A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
BR0212921A (pt) Composição farmacêutica com base em fondant
BR0317715A (pt) Composições e processos de uso de collajolie
CL2009001279A1 (es) Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03).
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
MXPA03008045A (es) Nuevas composiciones de medicamentos en base a agentes anticolinergicos e inhibidores de pde-iv.
BR0212386A (pt) Composto, formulação farmacêutica, e, uso de um composto
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
ATE357228T1 (de) Feste pharmazeutische formulierung enthaltend modafinil
SE0101932D0 (sv) Pharmaceutical combinations
IT1320080B1 (it) Composizione per uso farmaceutico o dietetico.
ATE454385T1 (de) Hiv-integrase-hemmers, pharmazeutischen zusammensetzung und ihre anwendung
CY1110449T1 (el) Συνδυασμος δοκεταξελης και φλαβοπιριδinολης
WO2005065639A3 (en) Novel pharmaceutical compositions
DE69917796D1 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
CR7198A (es) Tableta que contiene cetirizina y pseudoefedrina
NO20034524L (no) 5-leddete heterocykler, fremstilling og anvendelse derav som MAO inhibitorer og lipidperoksidasjonsinhibitorer, fremstilling derav oganvendelse derav sommedikamenter
WO2002057246A3 (en) Inhibitors of cruzipain and other cysteine proteases
AR028122A1 (es) Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones
FR2820423B1 (fr) Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
PKB1 Consensual patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20120229

Year of fee payment: 11

PK10 Patent expired after termination of 10 years for consensual patent

Effective date: 20120323